HealthEquity (HealthEquity) Risk Assessment

View and export this data going back to 2014. Start your Free Trial

What is HealthEquity Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of HealthEquity is: Low Risk: Strong fundamentals, worth long-term holding.

Competitive Comparison of HealthEquity's Risk Assessment

For the Health Information Services subindustry, HealthEquity's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HealthEquity's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, HealthEquity's Risk Assessment distribution charts can be found below:

* The bar in red indicates where HealthEquity's Risk Assessment falls into.

HealthEquity (NAS:HQY) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

HealthEquity Risk Assessment Related Terms

Thank you for viewing the detailed overview of HealthEquity's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

HealthEquity (HealthEquity) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » HealthEquity Inc (NAS:HQY) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

2HE:Germany 2HE:Germany

Address

15 West Scenic Pointe Drive, Suite 100, Draper, UT, USA, 84020

Website

https://www.healthequity.com

HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. Its technology allows customers to see their tax-advantaged healthcare savings, compare treatment options and pricing, pay healthcare bills, receive benefit information, and earn wellness incentives. The firm primarily partners with health plans and employers and serves as the custodian of its customers' health savings accounts (HSAs). HealthEquity also engages in reimbursement arrangements and offers healthcare incentives to its members. In addition, the company provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.

Executives

Delano Ladd	officer: Executive VP, GC & Corp. Secy.	15W. SCENIC POINTE DR., SUITE 100, DRAPER UT 84020
Ian Sacks	director	TOWERBROOK CAP., PARK AVENUE TOWER, 65 E 55TH ST., 27TH FLOOR, NEW YORK NY 10022
Elimelech Rosner	officer: EVP, Chief Technology Officer	5196 BELMORE COURT, SUWANEE GA 30024
Stephen Neeleman	director, officer: Founder and Vice Chairman	15 W. SCENIC POINTE DR., STE. 100, DRAPER UT 84020
Tyson D. Murdock	officer: EVP & CFO	2275 S. 2200 E., SALT LAKE CITY UT 84109
Jon Kessler	director, officer: President and CEO	15 W. SCENIC POINTE DR., STE. 100, DRAPER UT 84020
Frank Corvino	director	GREENWICH HOSPITAL, 5 PERRYRIDGE ROAD, GREENWICH CT 06830
Larry L Trittschuh	officer: EVP Chief Security Officer	1051 RUNNYMEDE ROAD, OAKWOOD OH 45419
James M Lucania	officer: EVP & CFO	101 WOLF DRIVE, THOROFARE NJ 08086
Gayle Furgurson Wellborn	director	123 TORRENCE CHAPEL ROAD, MOORESVILLE NC 28117
Debra Charlotte Mccowan	director	1436 CABRILLO AVENUE, BURLINGAME CA 94010
Paul Black	director	400 WOOD ROAD, BRAINTREE MA 02184
Edward Bloomberg	officer: Chief Operating Officer	13207 WINDSOR STREET, LEAWOOD KS 66209
Rajesh Natarajan	director	7500 DALLAS PARKWAY, SUITE 700, PLANO TX 75024
Evelyn S Dilsaver	director	C/O LONGS DRUG STORES CORPORATION, 141 NORTH CIVIC DRIVE, WALNUT CREEK CA 94596